Balancing Cost and Care Employers recognize the value of supporting employee health and productivity, but the surging cost of GLP-1 medications is prompting a serious reassessment of traditional benefit models
G., Lovric, E.,
The central clinical idea: when mitochondrial ATP production falls and oxidative stress rises, the brain may lose the energy and antioxidant reserve needed to regulate neurotransmission, maintain cell membranes, recycle methionine, produce SAM, clear adenosine and homocysteine, build glutathione and tolerate medications or supplements
Clinical trials showed A1c reductions of ~0.8%1.0% with albiglutide, a bit less than other GLP-1 RAs, but still significant
Adjustment: If response is inadequate, dose may be increased to 1.25 mg/kg (maximum)
"A nasal spray a day keeps the paleness away," Georgia Fox (@georgiafox11) told her 91,800 followers on TikTok